Telix Stock And Two ASX Growth Picks Backed By Insider Ownership

With oil prices, global bond yields and inflation expectations all in focus, a lot of attention is on interest rates and how companies handle a more volatile cost of capital. In this setting, many investors are looking at fast growing stocks where insiders hold meaningful stakes, which can help align management with shareholders when conditions are choppy. Our Fast Growing Stocks With High Insider Ownership screener highlights companies where growth expectations from analysts and management remain optimistic. In this article, you will see 3 stocks from the screener that stand out for closer research as you build or refine your portfolio.

Predictive Discovery (ASX:PDI)

Overview: Predictive Discovery is an Australia based gold company focused on exploring, developing and operating gold assets in West Africa, with its flagship Bankan Gold project in Guinea and two operating mines contributing to group production. It is aiming to turn a large resource base into a multi asset gold producer backed by ongoing exploration and development work.

Market Cap: A$3.45b

Predictive Discovery catches attention because it combines a large West African gold footprint, including the Bankan project, with recent operational updates showing strong plant throughput and recovery at its Kiniero and Nampala mines. Analysts expect significant growth in both revenue and earnings over the coming years, with a path to profitability within about 3 years, while some valuation models suggest the stock trades below estimated fair value. Set against that, investors need to weigh a short cash runway, continuing losses, heavy insider selling and an inexperienced management team, all in higher risk jurisdictions. The key consideration is whether the growth, resource base and production ramp justify accepting these financial and execution risks.

Predictive Discovery’s push to turn a large West African resource into a multi asset producer is eye catching, but the real story sits in the analyst forecasts that could reframe those risks, start with the analyst forecasts for Predictive Discovery

Telix Pharmaceuticals (ASX:TLX)

Overview: Telix Pharmaceuticals is an Australia based biopharma company that develops and commercialises radiopharmaceuticals, using targeted imaging and therapies to help doctors see and treat cancers such as prostate, kidney and brain tumours more precisely.

Operations: Telix Pharmaceuticals generates most of its revenue from Precision Medicine at about US$621.9m, with additional contributions from Manufacturing Solutions at about US$245.1m and Therapeutics at about US$9.3m, partially offset by inter segment eliminations.

Market Cap: A$5.53b

Telix Pharmaceuticals sits at the intersection of cancer imaging and treatment, with products like Illuccix and Gozellix already generating hundreds of millions in sales and a pipeline of therapeutics in Phase 3 trials for prostate and glioblastoma that could reshape the business if results support approvals. The company is currently expected by some analysts to grow earnings at about 41% a year and revenue at about 13% a year, yet the stock is described as trading on a lower P/S than many peers and some valuation models mark it well below certain estimates of fair value. Against that, Telix remains unprofitable, is lifting R&D and manufacturing spend and faces clinical, regulatory and pricing risks, particularly around its prostate programs and imaging competition, which makes it a higher risk, higher potential growth story within this screener.

Telix Pharmaceuticals looks like a high growth story hiding inside an unprofitable biopharma, with earnings and revenue expectations outpacing its current P/S. To see how that tension plays out, start with the analyst forecasts for Telix Pharmaceuticals

Lindian Resources (ASX:LIN)

Overview: Lindian Resources is a Perth based explorer focused on rare earths, bauxite and gold projects across Tanzania, Guinea, Malawi, Australia and Singapore, with its flagship Kangankunde Rare Earths project in Malawi moving from exploration toward first production.

Market Cap: A$1.49b

Lindian Resources is attracting attention because Kangankunde sits at the center of its growth plans, with first production at the rare earths project targeted for Q4 2026 and recent updates confirming the first production blast, active mining and stockpiling of ore. Forecasts point to very fast revenue and earnings growth, yet current revenue is minimal, the company remains unprofitable and shareholders have recently been diluted, all under a young management team and board with limited independence. For investors who can tolerate higher risk in exchange for exposure to rare earths and a fully funded project moving through commissioning, Lindian offers a story that could look very different once production ramps and the market can see how those forecasts measure up.

Lindian Resources is moving toward rare earths production with Kangankunde. The key question is how forecasts, funding and execution will stack up once ore turns into cash flow. Start with the analysis report for Lindian Resources

The three fast growing, high insider ownership stocks in this article are just a starting point. The full screener surfaces 98 more companies where insiders, analysts and management are aligned around compelling growth narratives, all captured in the Fast Growing Stocks With High Insider Ownership screener. Use Simply Wall St to identify and analyze the specific catalysts, insider signals and storylines that matter most to you so you can focus on the highest conviction opportunities from that wider list.

Take Control of Your Investment Journey

If Telix Pharmaceuticals or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Seeking Fresh Alternatives Beyond These Stocks?

Some of the sharpest breakouts start quietly, while momentum is still building and information is freshest. Before these ideas stop flying under the radar, consider reviewing them while interest is still limited.

• Spot sturdy compounding potential by reviewing a curated list of solid balance sheet and fundamentals (20 results) that keeps financial strength front and center while you assess which businesses deserve a closer look.
• Explore long term income momentum with hand picked 6 dividend fortresses that focus on businesses built to keep paying investors, even when sentiment drops and volatility bites.
• Review global infrastructure themes with carefully filtered 34 power grid technology and infrastructure stocks that connect you to companies positioned around energy demand and grid upgrades while the topic remains timely.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com